Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Evelo Biosciences, Inc.
Analyst Grade Summary
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
5
3
0
0
No Price
30.04.2026 20:00
Current Prices from Evelo Biosciences, Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
EVLO
USD
30.04.2026 20:00
0,0001 USD
-
NASDAQ
EVLO
USD
28.04.2026 13:50
0,000001 USD
-
Share Float & Liquidity
Free Float99,54 %
Shares Float18,9 M
Shares Outstanding18,98 M
Company Profile for Evelo Biosciences, Inc. Share
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also develops EDP1867, an inactivated investigational oral biologic, which is in Phase 1b for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
